ISSN: 0973-7510

E-ISSN: 2581-690X

Review Article | Open Access
Pallavi Rawat1, Vidya Chauhan1, Juhi Chaudhary1 and Neha Chauhan2
1Department of Microbiology, School of Basic and Applied Sciences, Shri Guru Ram Rai University, Patel Nagar, Dehradun, Uttarakhand, India.
2Department of Microbiology, College of Paramedical Sciences, Shri Guru Ram Rai University, Patel Nagar, Dehradun, Uttarakhand, India.
Article Number: 8002 | © The Author(s). 2023
J Pure Appl Microbiol. 2023;17(1):112-126.
Received: 01 August 2022 | Accepted: 09 January 2023 | Published online: 03 March 2023
Issue online: March 2023

Nontyphoidal Salmonella infections are common and remain a significant public health problem. The increasing cases of non-typhoidal Salmonella confirmed cases in past years from the United States, Europe, and low-income countries indicated that control programs aimed at inhibiting the contamination of food animals along the food chain had been largely ineffective. The majority of non-typhoidal Salmonella infections are mild gastroenteritis that rarely demands antimicrobial treatment. Salmonella is a gram-negative, multidrug-resistant, facultatively anaerobe bacterium. Salmonella is composed of approximately 2500 serotypes among which Salmonella enterica is responsible for more than 99% of human salmonellosis and morbidity. Salmonella enterica is an enteropathogenic foodborne bacteria isolated from animals that are responsible for zoonotic infections in humans, animals, and birds. Children who are young or immunocompromised, as well as those with underlying health issues like sickle cell disease, are highly susceptible to invasive disease. Antimicrobial treatment might be needed in case of invasive infections like meningitis, bacteremia, and osteomyelitis. Resistance to third-generation cephalosporins and fluoroquinolones in non-typhoidal Salmonella is a worrying concern in the 21st century. This review specifies various non-typhoidal Salmonella serotypes infections and their cases.


Antibacterial, Bacteraemia, Gastroenteritis, Immunocompromised, Osteomyelitis

Article Metrics

Article View: 37

Share This Article

© The Author(s) 2023. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.